“showed a trend”

The performance on the discrimination index of the novel object and the displaced object showed a trend between groups [NOR: F (3, 36) = 2.818, p = 0.053], SOR: [ F (3, 34) = 2.775, p = 0.056].

Although SPINK1 negative cases showed a trend for increased Gleason score (0.58, SE = 0.29, P = 0.053) using a linear regression model.

However, the proportion of patients enrolled into NHIF at diagnosis showed a trend to be higher in period 2 (39.8% vs. 59.0%; p = .053).

However, SLC6A4 TC/CC carriers showed a trend for softer stools (according to the BSS) compared with TT carriers ( P = .053). 3.8 Impact of DNA variants on transcription factor binding capacity We performed comparative transcription factor binding site analysis in the major and the minor (protective) haplotype genomic regions where the tag SNP rs2020938 resides.

Body mass did not change after training (0.5%, 95% CI -1.5 to 0.79, ES=−0.223, p=0.499), however percentage of body fat showed a trend to decrease (−4.5%, 95% CI -0.03 to 3.71, ES=0.705, p=0.053).

The HIIT showed a trend to reduce apoE ( p = 0.053) and reduced CETP proteins ( p < 0.01) in T2DM participants ( Figure 1C ).

The ECN showed a trend in the interaction time×condition ( p = 0.053) and an increase in rs-FC from pre to post ‘low’ exercise condition in the anterior cingulate cortex (ACC) ( Fig. 3 A).

Fever ( t > 38.5°C) only showed a trend toward a higher rate of blood culture positivity ( P = 0.053).

In analyses of the correlation of mutation status of CTNNB1 and efficacy of meloxicam treatment, mutation status showed a trend to associate with efficacy (p = 0.053, Table 2 ).

Instead, performance status (PS) ⩾2 (vs PS 0–1) predicted a lower OS ( P =0.044), and RBC transfusion ⩾20 times before transplantation (vs transfusion ⩽9 times) showed a trend toward a lower OS ( P =0.053).

Assessment of the regulatory CD25+FoxP3+ population also showed a trend for an increased frequency in the CD4+ subset ( p = 0.053) ( Figure 3C ) and an increased frequency for the CD4-CD8- subset ( p = 0.036) ( Figure 3D ) for patients ( n = 16, P5-20) compared to controls ( n = 20).

By RT-PCR, E-cadherin mRNA levels were not statistically different in primitive streak or in preingression epiblast regions of control versus treated embryos (Figure 4I ), though mRNA levels in the isolated preingression epiblast of SU5402 treated embryos showed a trend towards being reduced (p = 0.053).

The proteinuria reduction for all patients did not reach statistical significance, however, it showed a trend in that direction (p = 0.053).

Weighted mode MR also showed a trend toward reduced risks of hip OA (OR = 0.89, 95% CI: 0.80–1.00, P = 0.053).

In multivariate analyses, the female sex was independently associated with reduced all‐cause death (aHR 0.59; 95% CI 0.38–0.91, p = 0.019) and showed a trend toward higher AFDAS risk (aHR 1.57; 95% CI 0.99–2.49, p = 0.053).

Univariate analyses using the cox regression analysis ( Tables S1 – S5 ) revealed that recurrence was a significant prognosticator for PFS (HR, 3.986; 95% CI: 1.246–12.754, p = 0.020); salvage IMRT is a significant predictor for PFS (HR, 3.009; 95% CI: 1.007–8.991, p = 0.049); the use of ENI significantly improves LPFS (HR, 0.136; 95% CI: 0.019–0.964, p = 0.046); recurrence showed a trend to predict DMFS (HR, 5.373; 95% CI: 0.981–29.426, p = 0.053), and OS (HR, 5.886; 95% CI: 0.931–37.231, p = 0.060); salvage IMRT showed a trend to predict LPFS (HR, 5.840; 95% CI: 0.821–41.522, p = 0.078).

The percentage, but not the number, of CD163 + macrophages in BAL showed a trend for correlation with sputum (Rs = 0.267, p = 0.053).

Only patients using β-blocker showed a trend towards a decreased rate of distensibility loss at level 1 compared with patients not using β-blockers (p=0.053) ( table 3 ).

Visual assessment of the intensity of TRPV3 and TRPV4 immunostaining in keratinocytes in diabetic skin showed a trend for decrease of TRPV3 [median (range) control 1.5 (1.0–2.5), diabetic 1.0 (0.5–2.0), p = 0.053; Fig 11 ] but not TRPV4 (not shown).

Although not significant, the association of MBG and decline in GFR still showed a trend for significance after adjustment for baseline variables mean plasma calcium (β = -.375; p = .053), systolic BP (β = -.361; p = .056) and albuminuria (β = -.372; p = .063), but not for present diabetes mellitus type I or II at baseline (N = 6; β = -.339; p = .074), history of smoking at baseline (β = -.319; p = .107), and fasting glucose at baseline (β = -.301; p = .106), LDL at baseline (β = -.363; p = .081), bicarbonate (β = -.165; p = .442), and 24-hour sodium excretion (β = -.375; p = .077).

In the univariate analysis of the first-line setting, luminal A subtype showed a trend towards a correlation with a longer PFS ( p = 0.053).

Active smoking showed a trend towards increased risk (OR = 2.68, 95% CI: 0.99–7.28; p = 0.053), though this was not statistically significant.

Lesion uptake At the lesion level, the SUV max of the MRI-confirmed lesions showed a trend toward higher values in all organs with [ 68 Ga]Ga-DOTATATE compared with [ 18 F]AlF-OC (mean difference 13.3, p = 0.053).

The Reward*Time*Group ANOVA revealed that reaction times differed significantly between coin and circle (main effect Condition: F (1, 82) = 22.78, p < .001, see Fig 1C ) and showed a trend-wise decrease following a reversal (main effect Time: F (3, 246) = 2.6, p = .053).

The estimated means for ARR showed a trend of significativity among the 3 groups, with value of 0.001 for patients on OCR, 0.308 for patients on RTX, and 0.500 for patients on CLA ( p = 0.053).